 It also included royalty payments to Agenus for an undisclosed indication upon commercialization of a vaccine.Checkpoint Modulators (CPMs) interfere with cancers’ ability to “hijack” natural immune defense systems.To protect the body against disease, but without attacking healthy cells, the immune system uses multiple “checkpoint” systems.